Insights On Outsourced Drug Development
-
Expanding The OSD Toolbox: An Industry Approach To Adsorb Lipids Onto Powder Substrates
12/11/2024
Explore innovative solutions for improving the solubility and bioavailability of poorly soluble compounds in solid oral dosage forms to enhance drug delivery and therapeutic effectiveness.
-
Manufacturing CAR T Cell Therapies: Challenges, Insights And Solutions
6/16/2025
Manufacturing patient-specific cell therapies is a complex, multi-step process. Addressing key hurdles in production time, scalability, and cost is crucial to making these vital treatments more accessible.
-
qPCR Amplification Of Human Gastrointestinal Samples
6/15/2026
Residual inhibitors in GI-derived DNA can hinder qPCR performance. An optimized approach improves inhibitor tolerance and enables earlier target detection, delivering more reliable amplification.
-
Advancing Drug Safety And Improving R&D Productivity With The Liver-Chip S1
12/10/2024
Explore how the Emulate Liver-Chip S1 revolutionizes predictive toxicology by mimicking human liver biology, achieving superior sensitivity and specificity.
-
Optimize Your mAb Capture And Polishing With The Latest Resins And Tips
6/26/2025
Discover the latest innovations in monoclonal antibody purification and explore resin selection strategies to optimize product quality and improve process efficiency.
-
Integration From Formulation Development To Manufacturing, Packaging
2/27/2025
Adare Pharma Solutions' Pessano, Italy facility offers 220,000 sq. ft. of end-to-end services, including R&D, formulation development, clinical and commercial manufacturing, packaging, and advanced analytical capabilities.
-
NGS Identification Of Internal Tandem Duplications In FLT3
6/15/2026
Accurately identifying genetic duplications in leukemia requires more than conventional sequencing. See how advanced enrichment and analysis approaches enable deeper insight into variant structure.
-
Neuroinflammation In Alzheimer's Disease Pathway
3/24/2025
Recent research highlights neuroinflammation's role in AD progression, which suggests immune modulation as a potential therapeutic strategy. Learn more about neuroinflammatory processes in AD pathology.
-
Advancing Next Gen Antibodies: From AI Driven CLD To Manufacturing
6/2/2026
See how growing ADC complexity is driving the adoption of AI-enabled, data-driven CMC strategies that accelerate development, improve product insight, and strengthen manufacturing readiness.
-
Analyzing Biological Drug Effects In 3D
10/24/2025
Explore how 3D tumor microtissues paired with fluorescence-based assays offer scalable, high-sensitivity drug testing to deliver stronger signals and reproducible results compared to monolayer cultures.